ENT Clinical Trials in Grand Junction, CO
As of June 2026, 1 paid clinical trial is recruiting for ENT in Grand Junction, Colorado. ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial for ENT
·Clear filters·↓ Download CSVAbout research studies in Grand Junction
Grand Junction has approximately 55 recruiting research studies across a wide range of therapeutic areas. Colorado hosts the University of Colorado Anschutz Medical Campus, National Jewish Health, and Children's Hospital Colorado, with strong programs in pulmonology, oncology, and cardiovascular research.
Top Research Study Locations in Grand Junction
Researchers run research studies in Grand Junction, CO at 28 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Mary's Hospital and Regional Medical Center | Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 | 16 |
| Grand Valley Oncology | Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia, Endometrial Carcinoma | 9 |
| Cancer Centers of Colorado St. Mary's Regional Hospital | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 4 |
| Intermountain Health St. Mary's Regional Hospital | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 4 |
| ICON Eye Care | Age Related Cataracts, Open Angle Glaucoma (OAG), Cataract | 3 |
| Glaukos Investigative Site | Glaucoma, Persistent Corneal Epithelial Defect | 2 |
| Boeson Research GJT | Acute Treatment of Migraine | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 1 |
| Colorado West Healthcare System - Grand Valley Oncology | Carcinoma, Transitional Cell, Neoplasm Metastasis, Urinary Bladder Neoplasms | 1 |
| Colorado West Healthcare System dba Grand Valley Oncology | Extensive Stage Small-cell Lung Cancer, Small-cell Lung Cancer | 1 |
| Colorado West Healthcare System, dba Community Hospital | Advanced Breast Cancer, Advanced Gastric Cancer, Breast Neoplasms | 1 |
| Colorado West Healthcare System-Grand Valley Oncology | Lymphoma, Large B-Cell, Diffuse | 1 |
| Colorado West Healthcare, dba Grand Valley Oncology | Advanced Breast Cancer, Advanced Gastric Cancer, Breast Neoplasms | 1 |
| Dinosaur Pediatrics | Acute Treatment of Migraine | 1 |
| Intermountain Health | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| Local Institution - 0500 | Non-small Cell Lung Cancer | 1 |
| Ohio State University Telemedicine | Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | 1 |
| Redlands Mesa Surgery Center | Lumbar Spinal Stenosis | 1 |
| SCL Health | Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | 1 |
| SCL- St. Mary's Medical Center | Bladder Cancer, Breast Cancer, Cervical Cancer | 1 |
| Saint Mary's Regional Hospital - Cancer Centers of Colorado | Breast Cancer, Metastatic | 1 |
| St. Mary's Hospital and Medical Center | Parkinson's Disease | 1 |
| St. Mary's Medical Center | Atrial Fibrillation, Intracerebral Hemorrhage | 1 |
| St. Mary's Regional Hospital | Staphylococcus Aureus Bacteremia | 1 |
| St. Marys Hospital and Regional Medical Center-SCL Health Cancer Centers of Colorado | Breast Neoplasms | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
| VA Western Colorado Health Care System | Bladder Cancer, Breast Cancer, Cervical Cancer | 1 |
Active & Upcoming Studies in Grand Junction (2026)
Recruiting trials in Grand Junction grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (36 active studies)
- Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial · Phase 3 · NRG Oncology
- Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer · Phase 3 · Canadian Cancer Trials Group
Eye & vision (3 active studies)
- Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma · Avisi Technologies Inc.
- Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant · Phase 2, Phase 3 · Glaukos Corporation
Neurology & pain (2 active studies)
Cardiovascular (1 active study)
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery · Phase 3 · Yale University
Common conditions studied in Grand Junction
- Breast Neoplasms (4 active studies). Recruiting Breast Neoplasms studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-small Cell Lung Cancer (4 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Advanced Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Small Lymphocytic Lymphoma (3 active studies). Lymphoma research explores bispecific antibodies, CAR-T cell therapies, and new targeted agents for Hodgkin and non-Hodgkin lymphomas.
- Chronic Lymphocytic Leukemia (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Grand Junction
- Merck Sharp & Dohme LLC
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- AstraZeneca
Local regulations and guidelines
Clinical trials in Colorado are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Colorado trials are additionally subject to the Colorado Privacy Act (CPA), which adds consumer data-protection requirements to federal baseline standards.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Grand Junction. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Grand Junction
Hipa.ai aggregates every recruiting study in Grand Junction from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Grand Junction?
There are approximately 55 recruiting clinical trials in Grand Junction, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Grand Junction pay participants?
Most recruiting trials in Grand Junction compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Grand Junction?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Grand Junction?
The most common conditions under active study in Grand Junction include Breast Neoplasms (4), Non-small Cell Lung Cancer (4), Advanced Breast Cancer (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Grand Junction?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Grand Junction on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Grand Junction?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Grand Junction?
Recruiting research sites in Grand Junction include Saint Mary's Hospital and Regional Medical Center, Grand Valley Oncology, Cancer Centers of Colorado St. Mary's Regional Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Grand Junction right now?
The largest active categories in Grand Junction are Cancer & tumors (36), Eye & vision (3), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.